Recommendations for the diagnosis and management of persons with suspected vaccine-induced immune thrombotic thrombocytopenia (VITT)

• Main Author: Nancy Yomayusa (Author)
• Format: Book
• Published: Asociación Colombiana de Infectología, 2021-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: https://doi.org/10.22354/in.v26i1.987; 0123-9392
• Keywords: thrombocytopenia; covid-19 vaccines; thrombosis; Therapeutics. Pharmacology; RM1-950; Infectious and parasitic diseases; RC109-216
• Source: Infectio, Vol 26, Iss 1, Pp 3-10 (2021)

In recent months, rare cases of thrombosis at unusual sites associated with thrombocytopenia, occurring within a typical risk window (i.e., 4-28 days) after receiving SARS CoV2 vaccines, have been reported. Healthcare professionals should be prepared to detect these cases on time. The Expert Panel of the Knowledge Mana-gement and Transfer Network conducted a free search of the related literature. With the available information and the clinical expertise of the working group, we formulated, reviewed, and endorsed recommendations for the timely suspicion, diagnosis (case definitions, the use of initial laboratory and imaging tests, specific tests), and management of these thrombotic conditions. This document is considered a living document that will be updated as new evidence emerges, and re-commendations may change over time.